Literature DB >> 10833373

Surface expression of HLA-C antigen by human extravillous trophoblast.

A King1, T D Burrows, S E Hiby, J M Bowen, S Joseph, S Verma, P B Lim, L Gardner, P Le Bouteiller, A Ziegler, B Uchanska-Ziegler, Y W Loke.   

Abstract

In this paper definitive evidence that the classical class I product, HLA-C, is expressed on the surface of normal trophoblast cells is provided. HLA-C transcripts were sequenced from cDNA isolated from first trimester trophoblast cells obtained by flow cytometric sorting. Both paternal and maternal alleles were transcribed. HLA-C proteins were demonstrated by biochemical analysis and found on the cell surface in association with beta(2)-microglobulin. Upregulation of cell surface HLA-C but not HLA-G expression after interferon (IFN)-gamma treatment was demonstrated by flow cytometric analysis. Immunohistology has confirmed HLA-C is expressed by all extravillous subpopulations in vivo. The question of whether trophoblast HLA-C molecules interact with decidual NK cells expressing killer Ig-like receptors (KIR) has also been addressed. Our results demonstrate that extravillous trophoblast expresses at least two HLA class I molecules, HLA-G and HLA-C on the cell surface. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10833373     DOI: 10.1053/plac.1999.0496

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  50 in total

1.  Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions.

Authors:  Gal Markel; Dana Wolf; Jacob Hanna; Roi Gazit; Debra Goldman-Wohl; Yuval Lavy; Simcha Yagel; Ofer Mandelboim
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 2.  Immunology of pregnancy. Implications for the mother.

Authors:  Jill A Poole; Henry N Claman
Journal:  Clin Rev Allergy Immunol       Date:  2004-06       Impact factor: 8.667

3.  Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.

Authors:  Hugo G Hilton; Luca Vago; Anastazia M Older Aguilar; Achim K Moesta; Thorsten Graef; Laurent Abi-Rached; Paul J Norman; Lisbeth A Guethlein; Katharina Fleischhauer; Peter Parham
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

4.  Maternal-fetal HLA sharing and preeclampsia: variation in effects by seminal fluid exposure in a case-control study of nulliparous women in Iowa.

Authors:  Elizabeth W Triche; Karisa K Harland; Elizabeth H Field; Linda M Rubenstein; Audrey F Saftlas
Journal:  J Reprod Immunol       Date:  2013-08-06       Impact factor: 4.054

Review 5.  T cell behavior at the maternal-fetal interface.

Authors:  Patrice Nancy; Adrian Erlebacher
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

Review 6.  Understanding the role of killer cell immunoglobulin-like receptors in pregnancy complications.

Authors:  R Díaz-Peña; M J de Los Santos; Alejandro Lucia; P Castro-Santos
Journal:  J Assist Reprod Genet       Date:  2019-03-07       Impact factor: 3.412

Review 7.  Fetomaternal immune cross-talk and its consequences for maternal and offspring's health.

Authors:  Petra C Arck; Kurt Hecher
Journal:  Nat Med       Date:  2013-05-07       Impact factor: 53.440

8.  Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation.

Authors:  Shiqiu Xiong; Andrew M Sharkey; Philippa R Kennedy; Lucy Gardner; Lydia E Farrell; Olympe Chazara; Julien Bauer; Susan E Hiby; Francesco Colucci; Ashley Moffett
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

9.  Conformation of human leucocyte antigen-C molecules at the surface of human trophoblast cells.

Authors:  Richard Apps; Lucy Gardner; Sue E Hiby; Andrew M Sharkey; Ashley Moffett
Journal:  Immunology       Date:  2008-01-18       Impact factor: 7.397

Review 10.  Pathophysiology of placentation abnormalities in pregnancy-induced hypertension.

Authors:  Mitsuko Furuya; Junji Ishida; Ichiro Aoki; Akiyoshi Fukamizu
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.